Tryvio
My Prescription
Payment
Select pharmacy
$787.40
Print or send this coupon to your phone
CVSPowered byAbout Tryvio
Drug Details
Aprocitentan, marketed as Tryvio, is prescribed for adults with high blood pressure who do not achieve adequate control with other medications. It is used in conjunction with other blood pressure treatments. As an endothelin receptor antagonist, Tryvio works by blocking endothelin-1, a substance that constricts blood vessels, leading to increased blood pressure. By inhibiting this substance, Tryvio relaxes the blood vessels, facilitating easier blood flow and reducing blood pressure. The typical dosage is one tablet taken orally once a day. Common side effects include swelling (edema) and anemia. This medication plays a crucial role in preventing complications such as strokes, heart attacks, and kidney issues by effectively managing high blood pressure. Always consult healthcare professionals for advice tailored to your specific health needs.
Price history for Tryvio
30 Tablets, 12.5MG
Average retail price for Tryvio
Average SaveHealth price for Tryvio
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Tryvio dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 12.5MG | 30 Tablets | $807.80 | $26.93 |
Tryvio FAQs
Tryvio is not recognized as a medication name. It is possible that there might be a typographical error or a misunderstanding of the drug's name. If the user meant "Tysabri," it is used to treat multiple sclerosis and Crohn's disease. It is important to verify the correct name of the medication for accurate information.
Tryvio, also known as ocrelizumab, is a medication used to treat multiple sclerosis (MS). Clinical studies have shown that it is effective in reducing the frequency of relapses and slowing the progression of disability in patients with relapsing forms of MS. It is also the first medication approved for primary progressive MS, where it has been shown to slow disease progression. The effectiveness can vary among individuals, and it is important for patients to discuss with their healthcare provider to determine if it is the right treatment option for their specific condition.
As of the latest information available, there is no blood pressure medication known as Tryvio. It is possible that the name might be misspelled or not widely recognized in the medical community. It is recommended to verify the spelling or consult a healthcare professional for accurate information regarding any new medications.